首页> 外文期刊>Pharmaceutical Methods >A validated method for development of atovaquone as API and tablet dosage forms by UV spectroscopy
【24h】

A validated method for development of atovaquone as API and tablet dosage forms by UV spectroscopy

机译:一种经验证的紫外光谱法开发阿托伐醌作为API和片剂剂型的方法

获取原文
           

摘要

A simple new spectrophotometric method has been developed for estimation of Atovaquone in bulk and tablet dosage form. Atovaquone is estimated to be 251 nm in methanol. The Beer's law is obeyed in the concentration range of 1–10 μg/mL of the drug. The slope and intercept values are 0.111 and 0.012, respectively. Results of analysis of this method have been validated statically and by recovery studies. The method is applied to the marketed tablet formulation. A result of the analysis of tablet formulation, given as a percentage of label claim ± standard deviation, is 99.14 ± 0.66. The precision and accuracy has been examined by performing recovery studies and found to be 100.09 ± 1.14. The developed method is simple, sensitive, and reproducible, and can be used for the routine analysis of Atovaquone in bulk and tablet dosage form.Keywords: Atovaquone, methanol, pharmaceutical preparation, UV spectrophotometnric method
机译:已经开发了一种简单的新分光光度法,用于估计散装和片剂剂型中的阿托伐醌。甲醇中的Atovaquone估计为251 nm。药物的浓度范围为1–10μg/ mL,遵守比尔定律。斜率和截距值分别为0.111和0.012。该方法的分析结果已通过静态和回收研究验证。该方法适用于市售片剂制剂。片剂配方的分析结果(以标签声明的百分比±标准偏差表示)为99.14±0.66。通过进行恢复研究对精度和准确性进行了检查,结果为100.09±1.14。该方法简便,灵敏,重现性好,可用于阿托瓦醌的散剂和片剂剂型的常规分析。关键词:阿托伐醌,甲醇,药物制剂,紫外分光光度法

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号